ArticleDrugs - real world outcomes2022

Retrospective Analysis of Real-World Management of EGFR-Mutated Advanced NSCLC, After First-Line EGFR-TKI Treatment: US Treatment Patterns, Attrition, and Survival Data.

Jorge Nieva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.